Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. April 2020 07:00 ET | Quelle: Bioxytran Inc.

Bioxytran Published A Surrogate Marker for ARDS and Stroke Patients

Journal article published specifies the use of the MDX Viewer as an early warning sign of negative oxygen balance for use in Acute Respiratory Deficiency Syndrome (ARDS). BOSTON, MASSACHUSETTS,...
31. März 2020 07:00 ET | Quelle: Bioxytran Inc.

Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients

Company releases new COVID-19 slide deck on website. BOSTON, MASSACHUSETTS, March 31, 2020 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage biotechnology company with a...
30. März 2020 10:40 ET | Quelle: Bioxytran Inc.

Bioxytran to Internally Develop Novel Carbohydrate Galectin Inhibitor to Eliminate COVID-19 in Patients

Galectin research required to initiate clinical trials, subject to funding, will be based on internal development as opposed to a license as previously reported. BOSTON, MASSACHUSETTS, March 30,...
24. März 2020 08:48 ET | Quelle: Bioxytran Inc.

Bioxytran Licenses Novel Viral Inhibitor for COVID-19 Patients

The viral inhibitor is a polysaccharide designed to block galectins BOSTON, MASSACHUSETTS, March 24, 2020 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB:BIXT), a developmental stage biotechnology...
12. März 2020 07:00 ET | Quelle: Bioxytran Inc.

Bioxytran Guest Speaker on Perfusionists Continuing Education Program Discussing Acute Respiratory Distress Syndrome and Ways to Combat COVID-19

Live Youtube Broadcast with Expert Panelists on March 26, 2020 in MediWeb Studios BOSTON, MASSACHUSETTS, March 12, 2020 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage...
28. Februar 2020 10:25 ET | Quelle: Bioxytran Inc.

Bioxytran Positioned to Detect and Treat Stroke and Neuropathologies

Journal Article correlates different neurological pathologies with Brain Metabolic Score and examines a neurological case study BOSTON, MASSACHUSETTS, Feb. 28, 2020 (GLOBE NEWSWIRE) -- BIOXYTRAN,...
05. Februar 2020 07:00 ET | Quelle: Bioxytran Inc.

Bioxytran Seeking Partners for Late Stage Treatment of Wuhan Coronavirus using BXT-25

BXT-25 has the potential to treat late stage acute respiratory distress syndrome (ARDS) which is the leading cause of death in coronavirus patients. BOSTON, MASSACHUSETTS, Feb. 05, 2020 (GLOBE...
05. Dezember 2019 15:45 ET | Quelle: Bioxytran Inc.

Bioxytran’s MDX Viewer in conjunction with BXT-25 Will Validate Brain Metabolic Score as a Functional Endpoint in Ischemic Stroke

Journal Article Evaluates Viability of Neuroprotectants as a functional Endpoint in Ischemic Stroke and Other Diseases BOSTON, MASSACHUSETTS, Dec. 05, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC....
28. Oktober 2019 14:02 ET | Quelle: Bioxytran Inc.

Bioxytran Unveiling Concept of a new Vital Sign at Targeting Mitochondria World Congress

MDX Viewer provides essential data in critical care patientsBOSTON, MASSACHUSETTS, Oct. 28, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company focused...
16. Oktober 2019 07:00 ET | Quelle: Bioxytran Inc.

Latest Nobel Prize Validates Bioxytran at the Forefront of Scientific Discovery

Platform technology destined to measure and treat hypoxia BOSTON, MASSACHUSETTS, Oct. 16, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), is a developmental stage biotechnology...

Nächste Seite